More Related Content
What's hot
What's hot (20)
Viewers also liked
Viewers also liked (18)
Similar to G05 ards, fes, dvt, pe
Similar to G05 ards, fes, dvt, pe (20)
More from Claudiu Cucu
More from Claudiu Cucu (20)
Recently uploaded
Recently uploaded (20)
G05 ards, fes, dvt, pe
- 1. Acute Respiratory Distress Syndrome, Fat Embolism, & Thromboembolic Disease in the Orthopaedic Trauma Patient Steve Morgan, MD
- 2. Objectives • Define – ARDS – FES – Thromboembolic Disease • Understand Etiology & Physiology of each Condition • Understand – Prevention – Diagnosis – Treatment – Outcomes
- 3. ARDS • Acute respiratory failure in the post traumatic period characterized by a decreased PaO2 and a diffuse and often massive extravasation of fluid from the pulmonary vasculature to the interstitial space of the lungs.
- 4. ARDS Common Causes • Trauma • Massive Transfusion • Embolism • Sepsis • Aspiration • Abdominal Distension • Pulmonary Edema • Prolonged LOC • Cardiopulmonary Bypass • Pancreatitis • Major Burns MULTIFACTORAL
- 5. ARDS Etiology • ARDS related to MSOF • Release of inflammatory mediators results in organ dysfunction Trauma Inflammatory Mediators Organ Injury
- 6. ARDS PATHOPHYSIOLOGY • Systemic Inflammatory Mediators • Damage to Endothelial Lining • Increased Capillary Permeability • Fluid Extravasation • Alveolar Collapse • Decreased Pulmonary Compliance • Ventilation Perfusion Abnormalities • Arteriolar Hypoxemia
- 8. ARDS Chest CT Scan
- 9. ARDS Prevention • Limiting Blood Loss • Decreasing Transfusion Requirements • Early Fixation Of Unstable Fractures • Early Prophylactic Mechanical Ventilation
- 10. ARDS Treatment • Ventilator Support • Goals – Acceptable ABG’s – Prevent alveolar damage – Facilitate healing – Non-toxic FIO2 (< .60) • Research – Optimal ventilator settings
- 11. ARDS Outcome • Significant Cause of Mortality • Major Cause of Death in Patients with the Lowest ISS scores • 40% - 50% Mortality Rate – Mortality Rate Slowly Decreasing with Changing & Improving Therapy
- 12. Fat Embolism Syndrome (FES) • A Causative Factor In ARDS • Occurs Following A Long Bone Fracture • Characterized by: – Hypoxia – Mental Confusion – Petechial Rash
- 13. FES • Unanticipated Respiratory Distress • Diagnosis of Exclusion • Often Placed in The Category of ARDS • R/O other Causes of Hypoxia – Pulmonary Contusion – ARDS – Pneumonia
- 14. Etiology • Mechanical • Biochemical • No simple etiology
- 15. Mechanical Etiology • Fracture Liberates Fat • Intravasation - Fat Enters Venous System • Fat Causes Mechanical Obstruction
- 16. Mechanical Etiology • Systemic Fat Embolization – Patent Foramen Ovale – Pulmonary Pre- Capillary Shunts FES To Brain On MRI
- 17. Biochemical Etiology • Chemical Mediators Released @ time of Fracture • Fat Released at Time of Fracture • Fat Metabolism by Lipase releases Free Fatty Acids • Free Fatty Acids Result in Endothelial Lung Damage
- 18. Gurd et al FES Diagnosis • Major Criteria – Hypoxemia – CNS Depression – Petechial Rash – Pulmonary Edema • Minor Criteria – Tachycardia – Pyrexia – Retinal Emboli – Fat in Urine – Fat in Sputum – Thrombocytopenia – Decreased Hematocrit
- 19. Gurd et al FES Diagnosis • 1 Major Criteria • 4 Minor Criteria
- 20. FES Treatment • Supportive • Oxygen Therapy to maintain PaO2 • Mechanical Ventilation
- 21. FES Treatment • Steroids – Decrease endothelial damage – 30mg/kg initial dose repeated @ 4 Hours, 1gm dose repeated @ 8 Hours: Total 3 Doses • Complications - Frequent – Infection – GI • Steroid Therapy Avoided Secondary To Poor Risk Benefit Ratio
- 22. FES Prevention • Therapies – Fluid Loading – Hypertonic Fluid – Alcohol – Heparin – Dextran – Aspirin • Not Shown to be Effective
- 23. FES Prevention • Appropriate Splinting • Early Fracture Stabilization • Oxygen Therapy
- 24. Timing of Fracture Fixation • Early Fracture Fixation Optimal • Decreases Pulmonary Complications • Delayed Fracture Fixation – Increased Pulmonary Dysfunction
- 25. Type of Fracture Fixation -Controversial- • IM Nail - Reamed vs Un-Reamed – Increased Pulmonary Dysfunction With Reamed technique – Decreased with Unreamed Technique – Pape et al • IM Nail Reamed vs Plate Osteosynthesis – No Difference In Pulmonary Dysfunction • Bosse et al
- 26. Effect of IM Nailing • Canal Opening • Reaming • Nail Insertion • Unreamed Nail Insertion • All Cause Increased IM Pressure • All Cause Embolic Showers On Echocardiograms
- 27. Systemic Effects of Trauma Injury 12 hours 24 hours Postinjury Inflammatory Response Second Insult MOF IM Nailing As A cause of Secondary Systemic Injury
- 28. DVT Incidence • DVT occurance 60% if ISS >9. • 35%-60% DVT in pelvic fracture • PE-Most common preventable cause of death in trauma.
- 29. Virchow Triad
- 30. Hypercoaguability • Tissue Thromboplastin • Activated Procoagulants • Decreased Fibrinolytic Activity • Ineffective Heparin Clearance of Activated Clotting Factors • Catecholamine Release
- 31. Endothelial Injury • Direct Trauma to Vein @ time of Injury • Compression of the Vein Secondary to Fracture Position • Vein Manipulation @ Time of Fracture Fixation
- 32. Venous Stasis • Immobilization • Hypotension • Venous Occlusion – Edema – Fracture Position
- 33. DVT Prevention Goals • Clinically significant events – PE – Post Thrombotic syndrome • Low Complication Rate • High Compliance Rate • Cost Effective
- 34. DVT Prevention
- 35. Prophylaxis • Elastic Stockings • Mechanical Compression Devices • Inferior Vena Cava Filter (IVC) • Heparin • Warfarin • Low Molecular Weight Heparin • Aspirin
- 36. Mechanical Methods • Activity • Compression Stockings • Sequential Compression Device • Pedal Pumps Mechanism of Action • Decrease Stasis ∀ ↑ Fibrinolytic Activity
- 37. IVC Filter Indications • Anticoagulation Prohibited • High Risk Patients • DVT Prior to Necessary Surgery • PE Despite Anticoagulation
- 38. IVC Filter • Prevents Major PE • Low Morbidity – 96% Patent – 8% Migration – 4% PE • Filter insertion in the ICU • Expensive • Invasive • Does not treat DVT • Venous Insufficiency • Filter Occlusion • Permanent Advantages Disadvantage
- 39. Heparin • Heparin Potentiates Anti-Thrombin III Activity • Complex Inhibits – Thrombin (IIa), IXa, Xa • Heparin effect relative short duration – Reversed with Protamine Sulfate • Significant hemorrhage risk
- 40. SQ Heparin • Low Cost • No Monitoring • Convenient • Relatively Low Incidence of Bleeding • Insufficient Efficacy in High Risk Patients • Unpredictable Responses • Heparin Induced Thrombocytopenia Advantages Disadvantage
- 41. Low Molecular Weight Heparin (LMWH) • Potentiates Antithrombin III • Specific for Factor Xa • Minimal effects on other Factors
- 42. LMWH • No Monitoring • Increased Efficacy • Longer 1/2 life • Predictable Response • Lower risk of thrombocytopenia • Parenteral Administration • Cost Advantages Disadvantage
- 43. Aspirin • Inhibits cyclooxygenase • Decreases Platelet Adherence • ? Effectiveness in Musculoskeletal Trauma – Venous clots not typically found to have Platelet aggregates
- 44. Aspirin • Oral Administration • Tolerated well • In-expensive • No Monitoring • ? Efficacy when used alone • GI Intolerance • Prolonged anti-platelet effect Advantages Disadvantage
- 45. Warfarin • Blocks Vit K conversion in Liver • Effects Vit K Dependent Factors • Effects the Extrinsic Clotting System • Factor VII Effected first, Short Half Life • Monitored with Pro-Time – INR 2.0-2.5 • Reversed With Vitamin K or FFP
- 46. Warfarin • Effective • Oral Administration • Inexpensive • Requires Monitoring • Difficult to Reverse • Increased Bleeding Complications in Elderly Advantages Disadvantage
- 47. DVT screening • Physical Exam • Ascending venography • Duplex Ultrasonography • Magnetic Resonance Venography
- 48. Physical Examination • Calf Swelling • Palpable Venous Cords • Calf Pain • Homan’s Sign • All Unreliable
- 49. Ascending Contrast Venography • Sensitive for detection • Invasive • Dye Problems (allergies, renal) • Injection Site Irritation • Poor Pelvic Vein Evaluation • Gold Standard *Invasiveness,expense make ACV a poor screening tool
- 50. Doppler/Duplex Ultrasound • Comparable to Venogram • Non Invasive • No Morbidity • Poor Axial (i.e Pelvic) Vein Evaluation • Operator Dependent • Good Screening Tool – Noninvasive, reproducible
- 51. Magnetic Resonance Venography • Non Invasive • Good Visualization of Pelvic Veins • Difficult in Polytrauma Patient • Excellent specificity and sensitivity for suspected DVT • Controversial for screening
- 52. Pulmonary Embolism Clinical Shortness of breath, agitation, confusion Laboratory ↓ PaO2, ↑ A-a gradient Diagnostic studies V/Q scans Pulmonary Angiogram
- 53. Ventilation Perfusion Scan • Ventilation Perfusion mismatch • Results – Low probabiltity • 15% False Negative – Medium • Need Angiogram – High probability • 15% False Positive • Screening Tool
- 54. Pulmonary Angiogram • Angiographic Evaluation of pulmonary vascular tree • Allows Placement of IVC Filter in same setting if indicated • Sensitive - Standard in PE Detection. Diagnostic
- 55. Treatment PE • Anticoagulation • Filter for recurrent event despite anticoagulation • Thrombectomy – Serious Acute PE – Patient in extremous – Large identifiable PE
- 56. Treatment DVT/PE • Heparin – Bolus 10-15K units – Continuous Infusion • 1000Units/Hr – Goal → PTT 2x Control • Prevent Clot propagation and recurrent PE – Discontinue when Therapeutic on Wafarin • Warfarin – INR 2.0-3.0 – 3-6 Month Duration – Contraindicated in: • Pregnancy • Liver insufficieny • Poor Compliance – Prolonged Therapy may decrease recurrence rates (6 mos)
- 57. DVT/PE Outcome • No Diagnosis and Treatment – 30% Mortality • Correct Diagnosis and Therapy – 11% Mortality in First Hour – 8% Mortality After First Hour
- 58. DVT/PE Outcome • Post Thrombotic Syndrome – Valvular Incompetence – Venous Stasis – Edema – Cutaneous Atrophy • Recurrent DVT – 20% of Patients Return to General Index